Understanding health outcomes and pharmacoeconomics:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Burlington, MA
Jones & Bartlett Learning
2013
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XXII, 218 S. graph. Darst. |
| ISBN: | 9780763770990 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV040422320 | ||
| 003 | DE-604 | ||
| 005 | 20130110 | ||
| 007 | t | ||
| 008 | 120918s2013 xxud||| |||| 00||| eng d | ||
| 010 | |a 2011022068 | ||
| 020 | |a 9780763770990 |c pbk. : alk. paper |9 978-0-7637-7099-0 | ||
| 035 | |a (OCoLC)815897166 | ||
| 035 | |a (DE-599)BVBBV040422320 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-703 | ||
| 050 | 0 | |a RS100 | |
| 082 | 0 | |a 338.4/76151 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 245 | 1 | 0 | |a Understanding health outcomes and pharmacoeconomics |c George E. MacKinnon |
| 246 | 1 | 3 | |a Health outcomes and pharmacoeconomics |
| 264 | 1 | |a Burlington, MA |b Jones & Bartlett Learning |c 2013 | |
| 300 | |a XXII, 218 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Pharmaceutical industry |x Economic aspects | |
| 650 | 4 | |a Drugs |x Cost effectiveness | |
| 650 | 4 | |a Drug development |x Economic aspects | |
| 650 | 4 | |a Outcome Assessment (Health Care) | |
| 650 | 4 | |a Economics, Pharmaceutical | |
| 650 | 4 | |a Costs and Cost Analysis |x methods | |
| 650 | 4 | |a Outcome Assessment (Health Care) |x economics | |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Effizienz |0 (DE-588)4013585-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Effektivität |0 (DE-588)7859045-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 1 | |a Effektivität |0 (DE-588)7859045-0 |D s |
| 689 | 0 | 2 | |a Effizienz |0 (DE-588)4013585-8 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a MacKinnon, George E. |e Sonstige |0 (DE-588)1017959285 |4 oth | |
| 856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025274996&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-025274996 | ||
Datensatz im Suchindex
| _version_ | 1804149481614082048 |
|---|---|
| adam_text | UNDERSTANDING HEALTH OUTCOMES AND PHARMACOECONOMICS
/ MACKINNON, GEORGE E.
: C2012
TABLE OF CONTENTS / INHALTSVERZEICHNIS
DRUG APPROVAL PROCESS
MEASURING HEALTH STATUS AND HEALTH-RELATED QUALITY OF LIFE ASSESSMENT
HEALTH SURVEYS (DISEASE SPECIFIC AND GENERIC QUESTIONNAIRES) AND UTILITY
ASSESSMENT
OVERVIEW OF STATISTICAL ANALYSES IN BIOMEDICAL RESEARCH
RANDOMIZED CLINICAL TRIALS
SYSTEMATIC REVIEWS AND META ANALYSES
MEDICAL AND PRESCRIPTION CLAIMS DATABASES
USES OF PATIENT REGISTRIES IN EVIDENCE DEVELOPMENT
DECISION ANALYSIS
INTRODUCTION TO ECONOMIC ANALYSIS, COST DETERMINANTS AND MODELING
COST-OF-ILLNESS ANALYSIS AND BUDGET IMPACT MODELS
COST-BENEFIT ANALYSIS, COST-EFFECTIVENESS ANALYSIS AND COST-UTILITY
ANALYSIS
COMPARATIVE EFFECTIVENESS.
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| any_adam_object | 1 |
| author_GND | (DE-588)1017959285 |
| building | Verbundindex |
| bvnumber | BV040422320 |
| callnumber-first | R - Medicine |
| callnumber-label | RS100 |
| callnumber-raw | RS100 |
| callnumber-search | RS100 |
| callnumber-sort | RS 3100 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)815897166 (DE-599)BVBBV040422320 |
| dewey-full | 338.4/76151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151 |
| dewey-search | 338.4/76151 |
| dewey-sort | 3338.4 576151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01958nam a2200505zc 4500</leader><controlfield tag="001">BV040422320</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130110 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">120918s2013 xxud||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2011022068</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780763770990</subfield><subfield code="c">pbk. : alk. paper</subfield><subfield code="9">978-0-7637-7099-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)815897166</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040422320</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS100</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Understanding health outcomes and pharmacoeconomics</subfield><subfield code="c">George E. MacKinnon</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Health outcomes and pharmacoeconomics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Burlington, MA</subfield><subfield code="b">Jones & Bartlett Learning</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXII, 218 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Outcome Assessment (Health Care)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Costs and Cost Analysis</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Outcome Assessment (Health Care)</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Effizienz</subfield><subfield code="0">(DE-588)4013585-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Effektivität</subfield><subfield code="0">(DE-588)7859045-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Effektivität</subfield><subfield code="0">(DE-588)7859045-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Effizienz</subfield><subfield code="0">(DE-588)4013585-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">MacKinnon, George E.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1017959285</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025274996&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025274996</subfield></datafield></record></collection> |
| id | DE-604.BV040422320 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T00:23:43Z |
| institution | BVB |
| isbn | 9780763770990 |
| language | English |
| lccn | 2011022068 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025274996 |
| oclc_num | 815897166 |
| open_access_boolean | |
| owner | DE-703 |
| owner_facet | DE-703 |
| physical | XXII, 218 S. graph. Darst. |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Jones & Bartlett Learning |
| record_format | marc |
| spelling | Understanding health outcomes and pharmacoeconomics George E. MacKinnon Health outcomes and pharmacoeconomics Burlington, MA Jones & Bartlett Learning 2013 XXII, 218 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmaceutical industry Economic aspects Drugs Cost effectiveness Drug development Economic aspects Outcome Assessment (Health Care) Economics, Pharmaceutical Costs and Cost Analysis methods Outcome Assessment (Health Care) economics Arzneimittel (DE-588)4003115-9 gnd rswk-swf Effizienz (DE-588)4013585-8 gnd rswk-swf Effektivität (DE-588)7859045-0 gnd rswk-swf Arzneimittel (DE-588)4003115-9 s Effektivität (DE-588)7859045-0 s Effizienz (DE-588)4013585-8 s DE-604 MacKinnon, George E. Sonstige (DE-588)1017959285 oth LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025274996&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Understanding health outcomes and pharmacoeconomics Pharmaceutical industry Economic aspects Drugs Cost effectiveness Drug development Economic aspects Outcome Assessment (Health Care) Economics, Pharmaceutical Costs and Cost Analysis methods Outcome Assessment (Health Care) economics Arzneimittel (DE-588)4003115-9 gnd Effizienz (DE-588)4013585-8 gnd Effektivität (DE-588)7859045-0 gnd |
| subject_GND | (DE-588)4003115-9 (DE-588)4013585-8 (DE-588)7859045-0 |
| title | Understanding health outcomes and pharmacoeconomics |
| title_alt | Health outcomes and pharmacoeconomics |
| title_auth | Understanding health outcomes and pharmacoeconomics |
| title_exact_search | Understanding health outcomes and pharmacoeconomics |
| title_full | Understanding health outcomes and pharmacoeconomics George E. MacKinnon |
| title_fullStr | Understanding health outcomes and pharmacoeconomics George E. MacKinnon |
| title_full_unstemmed | Understanding health outcomes and pharmacoeconomics George E. MacKinnon |
| title_short | Understanding health outcomes and pharmacoeconomics |
| title_sort | understanding health outcomes and pharmacoeconomics |
| topic | Pharmaceutical industry Economic aspects Drugs Cost effectiveness Drug development Economic aspects Outcome Assessment (Health Care) Economics, Pharmaceutical Costs and Cost Analysis methods Outcome Assessment (Health Care) economics Arzneimittel (DE-588)4003115-9 gnd Effizienz (DE-588)4013585-8 gnd Effektivität (DE-588)7859045-0 gnd |
| topic_facet | Pharmaceutical industry Economic aspects Drugs Cost effectiveness Drug development Economic aspects Outcome Assessment (Health Care) Economics, Pharmaceutical Costs and Cost Analysis methods Outcome Assessment (Health Care) economics Arzneimittel Effizienz Effektivität |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025274996&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT mackinnongeorgee understandinghealthoutcomesandpharmacoeconomics AT mackinnongeorgee healthoutcomesandpharmacoeconomics |